Products

BioticsAI
BioticsAI
OB/GYN AI
BioticsAI is an AI-powered software that enhances prenatal ultrasound screenings by validating quality, detecting anomalies, and automating report generation, empowering obstetricians and improving patient care.

See all 1 product →

About BioticsAI

BioticsAI is a healthcare AI company that develops artificial intelligence-based software designed to enhance fetal and maternal ultrasound screening. Their platform aims to reduce diagnostic errors, which can be as high as 50% for fetal malformations, by validating the completeness and quality of screenings. The AI system integrates with existing ultrasound machines, providing real-time feedback to clinicians, localizing fetal vulnerabilities, identifying fetal anomalies, and automating report generation. This technology is intended to act as a “co-pilot” for obstetricians, improving diagnostic accuracy and workflow efficiency, and ultimately ensuring more comprehensive and patient-centric care for expectant mothers.

The company’s technology utilizes computer vision and machine learning, trained on millions of prenatal images, to annotate fetal ultrasound images with anatomical planes and structures. This supports both real-time and post-exam review, ensuring that critical anatomical markers are consistently captured. BioticsAI’s product is a vendor-agnostic, cloud-based software that can plug into current ultrasound workflows without requiring new hardware. The company has received FDA 510(k) clearance for its AI-driven fetal anatomy tool, specifically for routine mid-trimester (T2 and T3) fetal ultrasound examinations, and is preparing for a national rollout.

Focus Areas

fetal abnormality detection prenatal ultrasound screening medical imaging AI computer vision obstetrics AI automated medical reporting clinical decision support ultrasound quality assurance reproductive health

Business Intelligence

TechnologyAI-powered software integrating with existing imaging devices and PACS, utilizing computer vision and machine learning, built on proprietary datasets of prenatal ultrasound images, uses Label Studio Enterprise for data annotation.

What Physicians Need to Know

AI-Powered Fetal Ultrasound
BioticsAI utilizes artificial intelligence to enhance fetal ultrasound screenings, aiming to reduce diagnostic errors and improve the detection of fetal and maternal complications.
Fetal Anomaly Detection
The company's AI software analyzes ultrasound images in real-time to identify fetal abnormalities and flag potential issues for physicians during scans.
Ultrasound Quality Assurance
BioticsAI validates the completeness and quality of fetal anomaly screenings, identifies errors in the ultrasound process, and localizes problematic anatomical views.
Automated Medical Reporting
The platform automates the generation of high-quality documentation and reports, streamlining administrative tasks for clinicians.
Reproductive Health Diagnostics
While starting with obstetrics, BioticsAI aims to become an AI diagnostics platform for broader reproductive health, including gynecology, urology, and postnatal maternal care.
Computer Vision in Healthcare
BioticsAI's core technology relies on complex computer vision models trained on millions of prenatal images to accurately interpret ultrasound data.
Physician Tip

BioticsAI acts as an 'AI co-pilot,' integrating seamlessly into existing ultrasound workflows to provide real-time feedback and reduce operator-dependent errors. This can significantly improve diagnostic accuracy (up to 98%) and increase the completeness of ultrasound scans, allowing for more informed care decisions. The system is designed to be understandable by doctors, ensuring practical adoption and helping to mitigate the global skills shortage in obstetrics and sonography. By automating reporting and improving efficiency, physicians can dedicate more valuable time to patient interaction.

BioticsAI's tool integrates with existing ultrasound machines and can connect via a standard DIMSE connection for seamless integration within the same network as the ultrasound machine. The core technology stack relies on Label Studio Enterprise for efficient and compliant creation of proprietary, accurately-labeled ultrasound datasets, which is crucial for their machine learning algorithms and FDA clearance.

Products by BioticsAI

1 product in the directory

BioticsAI
BioticsAI
OB/GYN AI
BioticsAI is an AI-powered software that enhances prenatal ultrasound screenings by validating quality, detecting anomalies, and automating report generation, empowering obstetricians and improving patient care.

What the Web Says

BioticsAI is an AI-powered platform designed to improve the accuracy and efficiency of prenatal ultrasound diagnostics by helping obstetricians detect fetal abnormalities and pregnancy issues. The company has received significant recognition, including winning TechCrunch Disrupt 2023, and is preparing for FDA clearance and a national rollout. Their technology aims to mitigate misdiagnosis rates, which currently affect a significant portion of fetal malformation cases due to operator-dependent errors.

Overall: Positive

Strengths

  • High diagnostic accuracy (98%) in prenatal ultrasounds.
  • Increases completeness of ultrasound scans (from 70% to 90%).
  • Mitigates operator-dependent errors in ultrasound diagnostics.
  • Automates reporting and documentation, saving up to eight minutes per patient.
  • Integrates with any ultrasound machine.
  • Reduces administrative tasks for obstetricians, allowing more focus on patient care.

Limitations

  • Potential challenges with system uptime and high latency experienced by users.
  • Lack of configurable review workflows and quality assurance reporting in their open-source solution for data labeling.
  • Requires a large volume of high-quality, proprietary data for model training due to the absence of suitable public datasets.
  • Initial questions from physicians about AI taking over their job, though this is often overcome with product use.

Based on reviews from: YouTube (BioticsAI Boasts High Diagnostic Accuracy in Prenatal Ultrasounds), AI for the Betterment of Humanity: Spotlight on BioticsAI and the Future of Obstetrics, AI-powered ultrasound: BioticsAI is tackling misdiagnosis of unborn babies | Startmate, FDA 510(k) | Innolitics, BioticsAI Scales Lifesaving AI with Label Studio - HumanSignal, TechCrunch Disrupt Battlefield 2023 winner, Biotics AI, announced..., TechCrunch Disrupt 2023 (BioticsAI Pitches at Startup Battlefield), Reddit (r/AI_Agents), Indeed.com (Biotics Research Employee Reviews), Indeed.com (Biotics Research in Rosenberg, TX: Employee Reviews), Indeed.com (Biotics Research NW, Inc: Employee Reviews), Zippia (Working At Biotics Research: Company Overview and Culture), Reddit (r/biotech), Capterra Reviews from Real Users - TrustRadius, G2 Products | Read 8 Reviews on G2, Reddit (r/AI_Agents), Capterra review scraper for software ratings, user feedback, and product data - Browse AI, G2 Reviews 2026: Details, Pricing, & Features, Capterra's Proprietary Data & Research Methodologies, G2 Reviews | Read Customer Service Reviews of www.g2.com, G2: Business Software and Services Reviews, Quora (Does Capterra have legit reviewers?), MIT Technology Review (Apple is allowing anyone to access its Apple TV+ streaming service...)

Last updated: 2026-10-16

Videos

News, demos, and interviews about BioticsAI.

Loading videos...

Videos load interactively. If none appear, search YouTube for BioticsAI →

View all on YouTube

Press & Coverage

Data Phoenix
BioticsAI's AI-powered fetal abnormality detection software has been cleared by the FDA
BioticsAI, a 2023 TechCrunch Disrupt winner, received FDA clearance for its AI software that detects fetal abnormalities in ultrasound imaging, with plans to expand across U.S. healthcare systems.
2026-01
Cyprus Business Group
BioticsAI Secures FDA Approval for AI-Powered Fetal Ultrasound After 2023 Disrupt Battlefield Win
BioticsAI, winner of TechCrunch Disrupt Battlefield 2023, achieved FDA clearance for its AI software to detect fetal abnormalities via ultrasound, marking a move towards large-scale clinical deployment.
2026-01
TechCrunch
TechCrunch: BioticsAI, gains FDA clearance for its AI-powered fetal ultrasound product
BioticsAI received FDA 510(k) clearance for its comprehensive AI-driven fetal anatomy tool for routine midtrimester anatomy examinations, being the first US-founded company to achieve this for standard midtrimester fetal ultrasound.
2026-01
Euronews
AI-powered ultrasounds get medical approval. Here's how they may revolutionise prenatal screenings
BioticsAI's new AI software, cleared by the FDA, integrates with existing ultrasound machines to analyze images in real-time, detecting malformations and flagging issues for doctors during scans of pregnant women.
2026-01
Startmate
AI-powered ultrasound: BioticsAI is tackling misdiagnosis of unborn babies
BioticsAI integrates AI with ultrasound imaging to detect and diagnose fetal abnormalities, aiming to become the 'AI diagnostics platform for reproductive health' and reduce operator dependency in diagnoses.
unknown
HumanSignal
BioticsAI Scales Lifesaving AI with Label Studio
BioticsAI uses AI-powered software to validate fetal anomaly screenings, localize vulnerabilities, and automate report generation, relying on high-quality training data and Label Studio Enterprise for efficient annotation.
unknown
Medium (Salman Khan)
AI for the Betterment of Humanity: Spotlight on BioticsAI and the Future of Obstetrics
BioticsAI's AI-based platform integrates with ultrasound machines to prevent fetal malformation misdiagnoses, empowering obstetricians and streamlining compliance workflows.
2023-09
TechCrunch (Build Mode Podcast)
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder | TechCrunch's 'Build Mode' Podcast
BioticsAI CEO Robhy Bustami discusses the challenges of FDA approval, fundraising, and maintaining team motivation in the healthcare industry.
2026-04

Frequently Asked Questions

BioticsAI offers an AI solution called 'LUUS' (Live Ultrasound guidance System) that aims to enhance the quality and efficiency of prenatal ultrasound examinations. LUUS provides real-time guidance to sonographers, helping them acquire optimal ultrasound views and measurements, which can improve the accuracy of fetal anomaly detection and overall prenatal care.
BioticsAI's LUUS system uses AI to standardize ultrasound image acquisition, which is crucial for reliable anomaly detection. By guiding sonographers to capture high-quality, consistent images, the system aims to reduce variability and improve the diagnostic accuracy of prenatal ultrasounds. The company emphasizes that their technology is built on extensive datasets and validated through clinical studies.
BioticsAI's LUUS system has received CE Mark certification, indicating its conformity with European health, safety, and environmental protection standards. The company is also actively pursuing FDA clearance in the United States, which would allow its technology to be marketed and used in the US healthcare system.
BioticsAI's LUUS system is designed to integrate with existing ultrasound machines and hospital information systems, including EMRs. By standardizing image acquisition and potentially automating certain measurements, the technology aims to streamline the reporting process, reducing manual entry and improving the consistency of medical reports.
While specific pricing models are not publicly detailed, BioticsAI likely offers subscription-based or per-exam pricing for its LUUS system, common for AI-as-a-service in healthcare. The company emphasizes providing comprehensive support and training to healthcare professionals to ensure effective integration and utilization of their technology within clinical workflows.
BioticsAI has established partnerships with leading medical institutions and ultrasound equipment manufacturers to further develop and validate its technology. The company has successfully raised significant funding rounds, indicating investor confidence and contributing to its long-term stability and ability to continue innovating in the reproductive health diagnostics space.
BioticsAI adheres to stringent data privacy and security protocols, complying with regulations such as GDPR and HIPAA. The company employs robust encryption and anonymization techniques to protect patient data, ensuring that sensitive information used by their AI algorithms remains secure and confidential.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.